Contents Volume 13 · Issue 1 · 2019. Pages 1-130 13 articles
Frontiers of Medicine 2019, Volume 13, Issue 1, doi:
EDITORIAL
Prospects of immunotherapy for cancer
Frontiers of Medicine 2019, Volume 13, Issue 1, Pages 1-2 doi:10.1007/s11684-019-0691-y
REVIEW
Frontiers of Medicine 2019, Volume 13, Issue 1, Pages 12-23 doi:10.1007/s11684-019-0685-9
Monitoring checkpoint inhibitors: predictive biomarkers in immunotherapy
Frontiers of Medicine 2019, Volume 13, Issue 1, Pages 32-44 doi:10.1007/s11684-018-0678-0
Frontiers of Medicine 2019, Volume 13, Issue 1, Pages 45-56 doi:10.1007/s11684-017-0595-7
RESEARCH ARTICLE
Chimeric antigen receptor T cell targeting EGFRvIII for metastatic lung cancer therapy
Frontiers of Medicine 2019, Volume 13, Issue 1, Pages 57-68 doi:10.1007/s11684-019-0683-y
High-affinity T cell receptors redirect cytokine-activated T cells (CAT) to kill cancer cells
Frontiers of Medicine 2019, Volume 13, Issue 1, Pages 69-82 doi:10.1007/s11684-018-0677-1
Growth suppression of colorectal cancer expressing S492R EGFR by monoclonal antibody CH12
Frontiers of Medicine 2019, Volume 13, Issue 1, Pages 83-93 doi:10.1007/s11684-019-0682-z
Frontiers of Medicine 2019, Volume 13, Issue 1, Pages 94-103 doi:10.1007/s11684-019-0680-1
Frontiers of Medicine 2019, Volume 13, Issue 1, Pages 104-111 doi:10.1007/s11684-017-0568-x
Frontiers of Medicine 2019, Volume 13, Issue 1, Pages 112-120 doi:10.1007/s11684-017-0582-z
LETTER TO FRONTIERS OF MEDICINE
Frontiers of Medicine 2019, Volume 13, Issue 1, Pages 121-125 doi:10.1007/s11684-018-0615-2
CASE REPORT
Frontiers of Medicine 2019, Volume 13, Issue 1, Pages 126-130 doi:10.1007/s11684-017-0603-y